Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-iodine irrigation for adenoviral conjunctivitis
ACTRN12613000460707Phase 2Not yet recruiting
- Sponsor
- Ben Ashby
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of povidone-iodine in adenoviral conjunctivitis (2 arms), sponsored by Ben Ashby. Primary endpoint: Absence of adenovirus in tear film. Planned start May 2013; status: not yet recruiting.
02
Drugs
povidone-iodine
03
Conditions
adenoviral conjunctivitis
Beyond the preview
Go deeper on ACTRN12613000460707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000460707.